Microtubule organization and L-type voltage-activated calcium current in olfactory neuronal cells obtained from patients with schizophrenia and bipolar disorder

Schizophrenia Research

Volumn 143, Issue 2-3, 2013, Pages 384-389

  Solis Chagoyan H ^a   Calixto, E ^a   Figueroa, A ^b   Montano L M ^b   Berlanga, C ^a   Rodriguez Verdugo M S ^a   Romo, F ^a   Jimenez M ^a   Gurrola, C Zepeda ^a   Riquelme, A ^a   Benitez King G ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Biomarkers; Bipolar disorder; Calcium current; Microtubule; Schizophrenia

Indexed keywords

BETA TUBULIN III ANTIBODY; BIOLOGICAL MARKER; CALCIUM CHANNEL L TYPE; NIFEDIPINE; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; CELL FRACTIONATION; CELL LINEAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; HOMOGENATE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROTUBULE ASSEMBLY; NERVE CELL; NEUROEPITHELIUM; NOSE DISEASE; OLFACTORY NERVE; OLFACTORY NERVE CELL; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BIPOLAR DISORDER; CALCIUM; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; HUMANS; MICROTUBULES; NEURONS; NIFEDIPINE; PATCH-CLAMP TECHNIQUES; SCHIZOPHRENIA;

EID: 84872416456     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.035     Document Type: Article

References (44)

1. Arnold S.E., Lee V.M., Gur R.E., Trojanowski J.Q. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(23):10850-10854.
2. Benítez-King G., Riquelme A., Ortíz-López L., Berlanga C., Rodríguez-Verdugo M.S., Romo F., Calixto E., Solís-Chagoyán H., Jímenez M., Montaño L.M., Ramírez-Rodríguez G., Morales-Mulia S., Domínguez-Alonso A. A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases. J. Neurosci. Methods 2011, 201(1):35-45.
3. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473(7346):221-225.
4. Casini S., Tan H.L., Demirayak I., Remme C.A., Amin A.S., Scicluna B.P., Chatyan H., Ruijter J.M., Bezzina C.R., van Ginneken A.C., Veldkamp M.W. Tubulin polymerization modifies cardiac sodium channel expression and gating. Cardiovasc. Res. 2010, 85(4):691-700.
5. Cleveland D.W., Havercroft J.C. Is apparent autoregulatory control of tubulin synthesis nontranscriptionally regulated?. J. Cell Biol. 1983, 97(3):919-924.
6. Connor C.M., Crawford B.C., Akbarian S. White matter neuron alterations in schizophrenia and related disorders. Int. J. Dev. Neurosci. 2011, 29(3):325-334.
7. Cumming A.G., Matthews N.L., Park S. Olfactory identification and preference in bipolar disorder and schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261(4):251-259.
8. Curtis D., Vine A.E., McQuillin A., Bass N.J., Pereira A., Kandaswamy R., Lawrence J., Anjorin A., Choudhury K., Datta S.R., Puri V., Krasucki R., Pimm J., Thirumalai S., Quested D., Gurling H.M. Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes. Psychiatr. Genet. 2011, 21(1):1-4.
9. Ellison-Wright I., Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr. Res. 2010, 117(1):1-12.
10. Funakoshi S., Deutsch H.F. Human carbonic anhydrases. II. Some physicochemical properties of native isozymes and of similar isozymes generated in vitro. J. Biol. Chem. 1969, 244(13):3438-3446.
11. Gillespie C.S., Wilson R., Davidson A., Brophy P.J. Characterization of a cytoskeletal matrix associated with myelin from rat brain. Biochem. J. 1989, 260(3):689-696.
12. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57(1):65-73.
13. Gómez G., Rawson N.E., Hahn C.G., Michaels R., Restrepo D. Characteristics of odorant elicited calcium changes in cultured human olfactory neurons. J. Neurosci. Res. 2000, 62(5):737-749.
14. Goswami C., Kuhn J., Heppenstall P.A., Hucho T. Importance of non-selective cation channel TRPV4 interaction with cytoskeleton and their reciprocal regulations in cultured cells. PLoS One 2010, 5(7):e11654.
15. Hahn C.G., Gomez G., Restrepo D., Friedman E., Josiassen R., Pribitkin E.A., Lowry L.D., Gallop R.J., Rawson N.E. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. Am. J. Psychiatry 2005, 162(3):616-618.
16. Halpain S., Dehmelt L. The MAP1 family of microtubule-associated proteins. Genome Biol. 2006, 7(6):224.
17. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981, 391(2):85-100.
18. 2+. Neuron 1993, 10(5):797-804.
19. 2+ channel Ca(2+)-dependent inactivation in a mammalian central neuron involves the cytoskeleton. Pflugers Arch. 1994, 429(1):14-21.
20. Katz W., Weinstein B., Solomon F. Regulation of tubulin levels and microtubule assembly in Saccharomyces cerevisiae: consequences of altered tubulin gene copy number. Mol. Cell. Biol. 1990, 10(10):5286-5294.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
22. Ledesma M.D., Dotti C.G. Membrane and cytoskeleton dynamics during axonal elongation and stabilization. Int. Rev. Cytol. 2003, 227:183-219.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193(1):265-275.
24. Malan D., Gallo M.P., Bedendi I., Biasin C., Levi R.C., Alloatti G. Microtubules mobility affects the modulation of L-type I(Ca) by muscarinic and beta-adrenergic agonists in guinea-pig cardiac myocytes. J. Mol. Cell. Cardiol. 2003, 35(2):195-206.
25. Moberg P.J., Arnold S.E., Doty R.L., Gur R.E., Balderston C.C., Roalf D.R., Gur R.C., Kohler C.G., Kanes S.J., Siegel S.J., Turetsky B.I. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological and volumetric MRI measures. J. Clin. Exp. Neuropsychol. 2006, 28(8):1444-1461.
26. 2+ channel blockade. Endocrinology 2008, 149(5):2517-2526.
27. Op De Beeck L., Verlooy J.E., Van Buul-Offers S.C., Du Caju M.V. Detection of serum insulin-like growth factor binding proteins on western ligand blots by biotinylated IGF and enhanced chemiluminescence. J. Endocrinol. 1997, 154(2):R1-R5.
28. Ortíz-López L., Morales-Mulia S., Ramirez-Rodriguez G., Benitez-King G. ROCK regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J. Pineal Res. 2009, 46(1):15-21.
29. Pandya C.D., Howell K.R., Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 10.1016/j.pnpbp.2012.10.017.
30. Pascarel C., Brette F., Cazorla O., le Guennec J.Y. Effects on L-type calcium current of agents interfering with the cytoskeleton of isolated guinea-pig ventricular myocytes. Exp. Physiol. 1999, 84(6):1043-1050.
31. Poulain F.E., Sobel A. The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Mol. Cell. Neurosci. 2010, 43(1):15-32.
32. Rioux L., Ruscheinsky D., Arnold S.E. Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia. Psychiatry Res. 2004, 128(1):1-7.
33. Roisen F.J., Klueber K.M., Lu C.L., Hatcher L.M., Dozier A., Shields C.B., Maguire S. Adult human olfactory stem cells. Brain Res. 2001, 890(1):11-22.
34. Roskams A.J., Cai X., Ronnett G.V. Expression of neuron-specific beta-III tubulin during olfactory neurogenesis in the embryonic and adult rat. Neuroscience 1998, 83(1):191-200.
35. Rosoklija G., Keilp J.G., Toomayan G., Mancevski B., Haroutunian V., Liu D., Malespina D., Hays A.P., Sadiq S., Latov N., Dwork A.J. Altered subicular MAP2 immunoreactivity in schizophrenia. Prilozi 2005, 26(2):13-34.
36. Schwob J.E., Farber N.B., Gottlieb D.I. Neurons of the olfactory epithelium in adult rats contain vimentin. J. Neurosci. 1986, 6(1):208-217.
37. Shiraiwa T., Kashiwayanagi M., Iijima T., Murakami M. Involvement of the calcium channel beta3 subunit in olfactory signal transduction. Biochem. Biophys. Res. Commun. 2007, 355(4):1019-1024.
38. Somenarain L., Jones L.B. A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea. J. Psychiatry Res. 2010, 44(11):694-699.
39. Tajinda K., Ishizuka K., Colantuoni C., Morita M., Winicki J., Le C., Lin S., Schretlen D., Sawa A., Cascella N.G. Neuronal biomarkers from patients with mental illnesses: a novel method through nasal biopsy combined with laser-captured microdissection. Mol. Psychiatry 2010, 15(3):231-232.
40. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979, 76(9):4350-4354.
41. Tristan C., Shahani N., Sedlak T.W., Sawa A. The diverse functions of GAPDH: views from different subcellular compartments. Cell. Signal. 2011, 23(2):317-323.
42. Tuckwell H.C. Quantitative aspects of L-type Ca(2+) currents. Prog. Neurobiol. 2011, 96(1):1-31.
43. Turetsky B.I., Hahn C.G., Arnold S.E., Moberg P.J. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology 2009, 34(3):767-774.
44. Yamashita M. From neuroepithelial cells to neurons: changes in the physiological properties of neuroepithelial stem cells. Arch. Biochem. Biophys. 2012, 10.1016/j.abb.2012.07.016.